שווי הפעילות העסקית: exagen.com (XGN)

Exagen Inc. (XGN) protects its developments with patents, although competition in diagnostics is gradually lowering market barriers. The company is implementing an eco-friendly approach by minimizing paper documentation and optimizing waste recycling. The company's price evolution on the GURU.Markets platform shows that the Enterprise Value is 206.56. The business relies on the development of the AVISE system, which helps rheumatologists select personalized treatments for autoimmune pathologies to accelerate patient recovery.

Rising demand for AVISE diagnostics and the expansion of insurance coverage directly impact the fundamental business value displayed on the GURU.Markets platform. This indicator aggregates market capitalization with total debt minus liquid assets, determining the real acquisition price of Exagen Inc. (XGN) and allowing investors to assess the company's true financial burden during its scaling phase.